R&D What’s next for oncology research? Eliminating cancer as a cause of death is a highly ambitious goal, but oncology researchers are showing no signs of giving up the fight in 2023.
R&D CSL reflects on its future, past as new R&D lab opens Last month, global pharmaceutical maker CSL cut the ribbon on a brand-new research facility in Waltham, Massachusetts, wher
R&D Plotting the way forward on clinical trial diversity As the old adage goes, the first step towards solving a problem is admitting you have one.
R&D Into the bowels of gut research For people living with Inflammatory Bowel Disease (IBD), navigating life around the risk of flare-ups can be a messy and exhausting challenge.
R&D 12 Questions with Dr Michelle Longmire As the co-founder and chief executive officer of Medable, Dr Michelle Longmire is mission-driven to accelerate the development of new therapies for disease.
R&D Chronic kidney disease: Challenges and upcoming technologies Highlighting the impact of kidney disease, and promoting awareness and research, is crucial.
R&D Precision, speed, impact: Evolving mass spectrometry for med... MOBILion's Melissa Sherman explores the evolving role of mass spectrometry in drug discovery, complex molecule analysis, and medical research.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
